A Stahl, L Paschek, G Martin, NJ Gross, N … - FEBS letters, 2008 - Elsevier Anti-VEGF treatment has become accepted first-line treatment for choroidal
neovascularisation (CNV) in age-related macular degeneration. However,
VEGF-inhibition does not always lead to sustained CNV-reduction. In this ... Cited by 2 - Related articles - All 8 versions
AA Herzlich, J Tuo, CC Chan - PPAR research, 2008 - downloads.hindawi.com Page 1. Hindawi Publishing Corporation PPAR Research Volume 2008, Article
ID 389507, 11 pages doi:10.1155/2008/389507 Review Article ... Cited by 2 - Related articles - View as HTML - All 11 versions
BA Austin, B Liu, Z Li, RB Nussenblatt - Investigative Ophthalmology & Visual Science, 2009 - ARVO PURPOSE. High-temperature requirement serine protease (HTRA1) was identified as
a candidate age-related macular degeneration gene in multiple genetic studies in
humans. To date, no functional studies have shown a mechanism for HTRA1 to ... Cited by 1 - Related articles - All 3 versions
SB Bressler - Ophthalmology, 2009 - Elsevier Inhibition of angiogenesis is critical in the prevention and treatment of
neovascular age-related macular degeneration (AMD). Pathologic states such as
hypoxia, ischemia, or inflammation may tip the balance of proangiogenic and ... Related articles - All 2 versions
A Filip, S Clichici, A Muresan, D Daicoviciu, … - Experimental Oncology, 2008 - exp-oncology.com.ua The ideal cancer treatment should both destroy the primary tumor and at the same
time educate the immune system to recognize the tumor as foreign so that distant
metastases will also be eradicated. PDT by its effects on tumor cells and ... Related articles - View as HTML - All 5 versions
A Alexandra… - PPAR Research, 2008 - hindawi.com Age-related macular degeneration (AMD) is the leading cause of new blindness in
the western world and is becoming more of a socio-medical problem as the
proportion of the aged population increases. There are multiple efforts ... Related articles - Cached - All 2 versions
M Stur - Spektrum der Augenheilkunde, 2008 - Springer Zusammenfassung. Nach Einführung der intravitrealen Therapie ist es zu einem
deutlichen Rückgang der Anwen- dung der photodynamischen Therapie (PDT) mit
Verteporfin gekommen, weil die Resultate nach PDT schlechter sind als nach ... Related articles